Shares of Vertex Pharmaceuticals Inc. VRTX shed 2.36% to $438.92 Thursday, on what proved to be an all-around great trading ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2025 financial results on ...

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $438.92, representing a -2.36% change from its previous ...

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is one of the best future stocks to buy for the long term. On January 12, ...

Detailed price information for Halozyme Therapeutic (HALO-Q) from The Globe and Mail including charting and trades.

Detailed price information for Roche Holding Ltd (RHHVF) from The Globe and Mail including charting and trades.

Investors in Vertex Pharmaceuticals Incorporated VRTX need to pay close attention to the stock based on moves in the options ...

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face ...

The Davenport Core Leaders Fund finished the fourth quarter and the full year of 2025 achieving another strong year of double ...

Capital Group Core Balanced ETF earns a Buy rating for its balanced, multi-asset approach and strong risk-adjusted returns.